Scientists first confirmed microplastics in human blood in 2022, analyzing just 22 donors at Vrije Universiteit Amsterdam. The finding was striking: 77-80% of healthy adults carried detectable plastic fragments, averaging 1.6 micrograms per millilitre. Polyethylene terephthalate from beverage bottles. Polystyrene from packaging. Circulating. Right now, in most people reading this sentence.
The question everyone immediately asked was: is that dangerous? Four years later, the honest answer is that we do not know, and the reasons we do not know are more interesting than the headline number.
The Measurement Problem Nobody Wants to Talk About
A University of Michigan study published March 29, 2026 found that standard nitrile and latex lab gloves can introduce approximately 2,000 false positive microplastic particles per square millimeter of sample. Researcher Madeline Clough put it plainly: if you contact a sample with a gloved hand, you are likely imprinting stearates that inflate your results. Think of it like trying to count dust particles in a room while someone is shaking a feather duster. The dust is real. The count is wrong.
This does not mean microplastics in blood are a measurement artifact. Senior author Anne McNeil was careful to note that even if we are overestimating, there should be none. But it does mean that the 1.6 micrograms per millilitre figure, and every study built on similar methods, carries an asterisk we have not fully resolved. A single study is interesting. A replicated finding with validated methodology is knowledge. We are still working toward the second thing.
When Immune Cells Start Eating Plastic
Meanwhile, a February 2026 study in Progress in Orthodontics produced the first live cell imaging of macrophages, the immune system's cleanup crew, ingesting microplastics shed from orthodontic aligners. Co-author Warunek described the cells as having their immune responses skewed. The study tested 6 aligner materials and found 3D-printed polymers shed significantly more fragments than thermoformed versions.
This is biologically plausible and genuinely worth watching. Macrophages that are busy processing plastic fragments may be less available to fight actual infections. Chronic low-grade inflammation is a known precursor to a range of serious conditions. But: this was a cell culture study. Cells in a dish behave differently than cells inside a living immune system with redundancies, feedback loops, and compensatory mechanisms. The pathway from "macrophage ingests plastic" to "person develops disease" runs through years of longitudinal human data that nobody has yet collected.
I want to be fair to the skeptics here: the concentrations measured in blood are currently far below levels that produce toxicological effects in lab models. That is a real reassurance. But it assumes the relevant harm mechanism is direct toxicity, and the immune skewing data suggests the mechanism might be something subtler and cumulative, which toxicology thresholds are not designed to catch.
Regulatory authorities have made no formal hazard designation for microplastics in blood or in blood donation. That could mean genuine safety. It could also mean the evidence base is too young and too methodologically uncertain for regulators to act on. Both explanations are consistent with the current data.
What I want is straightforward: funded, multi-year cohort studies tracking microplastic concentrations in blood against actual health outcomes, using contamination-controlled lab protocols. Not more cross-sectional snapshots. Not more cell culture results extrapolated to human risk. The 2022 detection was a starting gun, not a finish line, and four years later we are still standing at the track debating whether the race is real.
